Equator Therapeutics Company
Equator Therapeutics develops a drug that burns calories and improves metabolism. It offers a drug that can solve obesity and type 2 diabetes problem because it addresses the root cause of metabolic disorders. Its drug will target mitochondria, the powerhouse of the cell. It will activate the protein that mitochondria naturally use to produce heat. The company's approach has been proven to reverse obesity and type 2 diabetes in animals. It has developed a high-throughput drug discovery platform to identify compounds that selectively activate its target protein, without side effects.
Technology:
Data-driven Technologies
Industry:
Geroscience
Headquarters:
San Francisco, California, United States
Zip:
1-10
Founded Date:
2020-01-01
Employees Number:
1-10
Funding Status:
Seed
Acquisitions Number:
2
Investors Number:
150000
Total Funding:
150000
Estimated Revenue:
$1M to $10M
Last Funding Date:
Convertible Note
Last Funding Type:
founders@equatortherapeutics.com
Register and Claim Ownership